Clinical Research Services

The combination of the MHRA Accreditation and the expert knowledge of conducting 500 Early Phase Studies ensure Richmond Pharmacology can provide you with a service that meets your needs.

Adaptive Phase I Studies

Rapid approval, flexible conduct, government agency accredited facility, experienced

TQT Studies

Unique all under one roof setting, world-class specialist clinic and core laboratory



Bridiging Studies

Longstanding European specialist provider of Japanese and Japanese Bridging studies since 2002

Patient Recruitment

Innovative record breaking specialist early phase patient recruitment



Latest news

Dr Jorg Taubel attending ACCP in San Diego

05th Sep 2017

Dr Jorg Taubel will be attending the ACCP in San Diego, September 17-19, where he will be discussing his latest

Read more ›

DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings

Read more ›

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

Read more ›